Ge Healthcare Technologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Ge Healthcare Technologies Inc in the third quarter 2026?
Ge Healthcare Technologies Inc achieved a return on average equity (ROE) of 20.04 % in its third quarter 2026, which is below Ge Healthcare Technologies Inc 's average return on equity, which stands at 22.77%.

ROE has advanced compared to 19.37% in the second quarter 2026, due to net income growth.

Within the Medical Laboratories industry 6 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 652 to 689.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	16.11 %	12.9 %	16 %	22.76 %	-
Y / Y Net Income Change	32.54 %	12.2 %	-30.1 %	-18.32 %	-5.31 %
Net Income (TTM) in Millions	2,189	2,038	1,977	2,154	2,289
Return On Equity (TTM)	20.04 %	19.37 %	19.37 %	21.9 %	24.47 %
GEHC's Total Ranking	# 689	# 652	# 491	# 440	# 438
Equity (TTM) in Millions	11,630	10,989	10,680	10,390	10,016
Seq. Equity Change	5.83 %	2.89 %	2.79 %	3.73 %	2.91 %
Seq. Net Income Change	9.63 %	36.5 %	-31.73 %	29.74 %	-7.2 %

Back to GEHC Management Effectiveness >> GEHC's 5 Years Annual ROE >> Compare GEHC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 7
Sector	# 84
Overall	# 689

Return On Equity Statistics
High	Average	Low
26.61 %	22.77 %	19.37 %
(Mar 31 2025)		(Mar 31 2026)

GEHC Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Equity in Millions	10,390	8,464	7,145	0	0
Y / Y Equity Change	22.76 %	18.46 %	-	-	-
Net Income in Millions	2,154	2,050	1,614	0	0
Y / Y Net Income Change	5.07 %	27.01 %	-	-	-
Return On Equity	20.73 %	24.22 %	22.59 %	-	-

Back to GEHC Management Effectiveness >> GEHC's 5 Years Annual ROE >> Compare GEHC ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 20.73 %, despite net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GEHC's' Return on Equity at Yahoo Finance
GEHC's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GEHC's Competitors
Subscribers only: Roe for Ge Healthcare Technologies Inc 's Suppliers
Subscribers only: Return On Equity for GEHC's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Aurinia Pharmaceuticals Inc	51.92 %
Nurix Therapeutics Inc	49.34 %
Carlisle Companies Incorporated	44.18 %
Bristol myers Squibb Company	43.83 %
Zevra Therapeutics Inc	38.02 %
Dexcom Inc	36.56 %
Rallybio Corporation	36.35 %
Caredx Inc	34.08 %
Chemed Corporation	32.10 %
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %
Vertex Pharmaceuticals Inc	20.08 %
Ge Healthcare Technologies Inc	20.04 %

Date modified: 2026-10-29T17:23:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.